Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease

Molecular Pharmacology

Volumn 57, Issue 2, 2000, Pages 342-352

  Dunah, Anthone W ^a   Wang, Yuehua ^b   Yasuda, Robert P ^c   Kameyama, Kimihiko ^c   Huganir, Richard L ^c   Wolfe, Barry B ^b   Standaert, David G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID; OXIDOPAMINE; RECEPTOR SUBUNIT; SERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; IMMUNOPRECIPITATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT;

ANIMALS; ANTIPARKINSON AGENTS; CELL MEMBRANE; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; LEVODOPA; MALE; NEURONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0033974271     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Albin RL, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB and Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study. Neuroscience 46:35-48.
2. Blanchet PJ, Papa SM, Metman LV, Mouradian MM and Chase TN (1997) Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease. Neurosci Biobehav Rev 21:447-453.
3. Chase TN, Oh JD and Blanchet PJ (1998) Neostriatal mechanisms in Parkinson's disease. Neurology 51:330-835.
4. Dingledine R, Borges K, Bowie D and Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61.
5. Dunah AW, Yasuda RP, Luo J, Wang Y-H, Davila-Garcia MI, Gbadegesin M, Vicini S and Wolfe BB (1996) Regional and ontogenetic expression of the NMDA receptor subunit NR2D protein in rat brain using a subunit-specific antibody. J Neurochem 67:2335-2345.
6. Dunah AW, Yasuda RP, Luo J, Wang Y-H and Wolfe BB (1998a) Subunit composition of NMDA receptors in the rat central nervous system that contain the NR2D subunit. Mol Pharmacol 53:429-437.
7. Dunah AW, Yasuda RP and Wolfe BB (1998b) Developmental regulation of tyrosine phosphorylation of the NR2D NMDA glutamate receptor subunit in the rat central nervous system. J Neurochem 71:1926-1934.
8. Hall RA and Soderling TR (1997) Differential surface expression and phosphorylation of the N-methyl-D-aspartate receptor subunits NR1 and NR2 in cultured hippocampal neurons. J Biol Chem 272:4135-4140.
9. Hisatsune C, Umemori H, Inoue T, Michikawa T, Kohda K, Mikoshiba K and Yamamoto T (1997) Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin. J Biol Chem 272:20805-20810.
10. Kaur S and Starr MS (1997) Differential effects of intrastriatal and intranigral injections of glutamate antagonists on motor behaviour in the reserpine-treated rat. Neuroscience 76:345-354.
11. Klockgether T and Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats. Ann Neurol 28:539-546.
12. Klockgether T and Turski L (1993) Toward an understanding of the role of glutamate in experimental Parkinsonism: Agonist-sensitive sites in the basal ganglia. Ann Neurol 34:585-593.
13. Lau LF and Huganir RL (1995) Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 270:20036-20041.
14. Laurie DJ and Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol 268:335-345.
15. Luo JH, Bosy TZ, Wang YH, Yasuda RP and Wolfe BB (1996) Ontogeny of NMDA R1 subunit protein expression in five regions of rat brain. Dev Brain Res 92:10-17.
16. Luo J, Wang Y, Yasuda RP, Dunah AW and Wolfe BB (1997) The majority of N-methyl-D-aspartate receptor complexes in adult rat cerebral cortex contain at least three different subunits (NR1/NR2A/NR2B). Mol Pharmacol 51:79-86.
17. Lynch DR, Anegawa NJ, Verdoorn T and Pritchett DB (1994) N-methyl-D-aspartate receptors - Different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Mol Pharmacol 45:540-545.
18. Lynch DR and Gallagher MJ (1996) Inhibition of N-methyl-D-aspartate receptors by haloperidol: Developmental and pharmacological characterization in native and recombinant receptors. J Pharmacol Exp Ther 279:154-161.
19. Marin C, Papa S, Engber TM, Bonastre M, Tolosa E and Chase TN (1996) MK-801 prevents levodopa-induced motor response alterations in parkinsonian rats. Brain Res 736:202-203.
20. Menegoz M, Iau L-F, Hervé D, Huganir RL and Girault J-A (1996) Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions. NeuroReport 7:125-128.
21. Moreili M, Fenu S, Pinna A and Di Chiara G (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260:402-408.
22. O'Dell SJ and Marshall JF (1996) Chronic L-dopa alters striatal NMDA receptors in rats with dopaminergic injury. NeuroReport 7:2457-2461.
23. Oh JD, Russel D, Vaughan CL and Chase TN (1998) Enhanced tyrosine phosphorylation of striatal NMDA receptor subunits: Effect of doapminergic denervation and L-DOPA administration. Brain Res 813:150-159.
24. Papa SM, Boldry RC, Engber TM, Kask AM and Chase TN (1995) Reversal of levodopa-induced motor fluctuations in experimental parkinsonism by NMDA receptor blockade. Brain Res 701:13-28.
25. Papa SM, Engber TM, Boldry RC and Chase TN (1993) Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists. Eur J Pharmacol 232:247-253.
26. Paxinos G and Watson C (1986)The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando, Florida.
27. Petralia RS, Yokotani N and Wenthold RJ (1994) Light and electron microscope distributions of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J Neurosci 14:667-696.
28. Porter RHP, Greene JG, Higgins DS and Greenamyre JT (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 14:7192-7200.
29. Raman IM, Tong G and Jahr CE (1996) Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron 16:415-421.
30. Rosenblum K, Berman DE, Hazvi S, Lamprecht R and Dudai Y (1997) NMDA receptor and the tyrosine phosphorylation of its 2B subunit in taste learning in the rat insular cortex. J Neurosci 17:5129-5135.
31. Rostas JA, Brent VA, Voss K, Errington ML, Bliss TV and Gurd JW (1996) Enhanced tyrosine phosphorylation of the 2B subunit of the N-methyl-D-aspartate receptor in long-term potentiation. Proc Natl Acad Sci USA 93:10452-10456.
32. Shi SH, Hayashi Y, Petralia RS, Zaman SH, Wenthold RJ, Svoboda K and Malinow R (1999) Rapid spine delivery and redistribution of AMPA receptors after synaptic NMDA receptor activation. Science (Wash DC) 284:1811-1816.
33. Snyder GL, Fienberg AA, Huganir RL and Greengard P (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 18:10297-10303.
34. Standaert DG and Stern MB (1993) Update on the management of Parkinson's disease. Med Clin. N. Am. 77:169-183.
35. Standaert DG, Testa CM, Penney JB and Young AB (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J Comp Neurol 343:1-16.
36. Thanos PK, Jhamandas K and Beninger RJ (1992) N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol. Brain Res 589:55-61.
37. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT and Huganir RL (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272:5157-5166.
38. Ulas J and Cotman CW (1996) Dopaminergic denervation of striatum results in elevated expression of NR2A subunit. NeuroReport 7:1789-1793.
39. Ungerstedt U and Arburthnott GW (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485-493.
40. Wang Y-H, Bosy TZ, Yasuda RP, Grayson DR, Vicini S, Pizzorusso R and Wolfe BB (1995) Characterization of NMDA receptor subunit-specific antibodies: distribution of NR2A and NR2B receptor subunits in the rat brain and ontogenic profile in cerebellum. J Neurochem 65:176-183.
41. Wang YT and Salter MW (1994) Regulation of NMDA receptors by tyrosine kinases and phosphatases. Nature (Lond) 369:233-235.
42. Williams K, Zappia AM, Pritchett DB, Shen YM and Molinoff PB (1994) Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol Pharmacol 45:803-809.
43. Wüllner U, Brouillet E, Isacson O, Young AB and Penney JB (1993) Glutamate receptor binding sites in MPTP-treated mice. Exp Neurol 121:284-287.
44. Wyszynski M, Lin J, Rao A, Nigh E, Beggs AH, Craig AM and Sheng M (1997) Competitive binding of a-actinin and calmodulin to the NMDA receptor. Nature (Lond) 385:439-442.
45. Yu XM, Askalan R, Keil Gn and Salter MW (1997) NMDA channel regulation by channel-associated protein tyrosine kinase Src. Science (Wash DC) 275:674-678.